Acumen Pharmaceuticals, Inc.（ABOS）内部人交易：高管与董事近期交易
过去 18 个月，共有 19 位内部人为 Acumen Pharmaceuticals, Inc.（ABOS）报告了 89 笔 Form 4 交易（最近一笔 2026-06-17）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-17 | Porter Derrell | 董事 | 买入 | 6,460 | $6,912 |
| 2026-06-17 | Porter Derrell | 董事 | 卖出 | 6,460 | $15,181 |
| 2026-06-17 | Porter Derrell | 董事 | 卖出 | 12,800 | $29,824 |
| 2026-06-17 | Porter Derrell | 董事 | 买入 | 13,040 | $13,953 |
| 2026-06-17 | Porter Derrell | 董事 | 卖出 | 13,040 | $30,383 |
| 2026-06-10 | Fountain Nathan B | 董事 | 卖出 | 6,400 | $14,272 |
| 2026-06-05 | Stoppel Laura | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Drapkin Kimberlee C | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Golumbeski George | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Stalfort John A III | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Fountain Nathan B | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Porter Derrell | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Ives Jeffrey L. | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | RA Capital Healthcare Fund LP | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Kolchinsky Peter | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | Shah Rajeev M. | 董事 | 买入 | 35,500 | $0 |
| 2026-06-05 | RA Capital Nexus Fund II, L.P. | 董事 | 买入 | 35,500 | $0 |
| 2026-03-18 | RA Capital Healthcare Fund LP | 董事 | 买入 | 6.1M | $20.0M |
| 2026-03-18 | RA CAPITAL MANAGEMENT, L.P. | 董事 | 买入 | 6.1M | $20.0M |
| 2026-03-18 | Kolchinsky Peter | 董事 | 买入 | 6.1M | $20.0M |
| 2026-03-18 | Shah Rajeev M. | 董事 | 买入 | 6.1M | $20.0M |
| 2026-03-18 | RA Capital Nexus Fund II, L.P. | 董事 | 买入 | 6.1M | $20.0M |
| 2026-03-10 | Meisner Derek M | Chief Legal Officer & Corp Sec | 买入 | 2,090 | $3,866 |
| 2026-03-10 | Meisner Derek M | Chief Legal Officer & Corp Sec | 卖出 | 2,090 | $6,813 |
来源：SEC Form 4 申报文件 · 截至 2026-06-17